Browse Biliary tract cancer topic

Subtopics (6) Care and treatment Diagnosis Drug therapy Health aspects Physiological aspects Research

Articles 1-15 out of 15 article(s) Title Author Type Date Words Pro-Pharmaceuticals Announces "Compassionate Use" IND for DAVANAT(R) to Treat Biliary Cancer Patient. Aug 16, 2007 942 Pro-Pharmaceuticals Announces Boston Medical Center Dosing Patients with DAVANAT(R) in Advanced Biliary Cancer Trial. Jul 25, 2007 879 Pro-Pharmaceuticals Announces Tampa General Hospital Dosing Patients with DAVANAT(R)/5-FU in Phase II, First Line, Advanced Biliary Cancer Clinical Trial. Apr 4, 2007 1037 Pro-Pharmaceuticals Submits Orphan Drug Status Application to European Medicines Agency Co-administration of DAVANAT(R) with 5-FU to Treat Cholangiocarcinoma. Feb 28, 2007 1486 Pro-Pharmaceuticals Announces Dosing of Patients with DAVANAT(R) in Phase II, First Line, Advanced Biliary Cancer Clinical Trial. Jan 23, 2007 1005 Pro-Pharmaceuticals Signs Agreement with CESAR to Expand Recruitment of Patients for the Phase II Biliary Cancer Trial. Dec 19, 2006 910 Advances in the endoscopic management of patients with pancreatic and biliary malignancies. Brugge, William R. Dec 1, 2006 5676 CONMED Enters into a Distribution Agreement with W.L. Gore & Associates. Oct 27, 2006 898 Pro-Pharmaceuticals Announces Cash Payment of Debentures & Clinical Trial Progress. Sep 28, 2006 803 Pro-Pharmaceuticals Updates Clinical Trials Progress. Aug 30, 2006 950 Pro-Pharmaceuticals Receives 'Compassionate Use' IND for Use of DAVANAT(R)/5-FU to Treat Another Patient with Cholangiocarcinoma. Feb 2, 2006 376 Elevated CA 19-9 levels in a patient with Mirizzi syndrome: case report. Marcus, Erin N. Feb 1, 2006 2064 Fury over bug death. Jan 16, 2006 125 Cholangiocarcinoma metastatic to the neck: first report of a case. Stack, Brendan C., Jr. Nov 1, 2002 971 Cholangiocarcinoma and Pro-Inflammatory Cytokines. May 1, 2000 1778